Real-Life Management of Patients with Retinal Vein Occlusion Using I-Macula Web Platform

Table 3

Number of letters at baseline and 12 months follow-up in 37 eyes with macular edema secondary to retinal vein occlusion treated with DEX implant and/or ranibizumab.

	RVO		CRVO		BRVO
	Baseline	12 M	Baseline	12 M	Baseline	12 M
Mean	37.9 ± 26	46.9 ± 23	28.2 ± 28	36.5 ± 36	46.1 ± 26	55.7 ± 23
Min–Max	0–80	0–79	3–65	0–74	0–80	0–79
		0.0235		0.1		0.09
Mean change		8.9		8.3		9.5